SIR ePoster Library

531 - Combining neutrophil-lymphocyte ratio (NLR) with serum albumin and bilirubin (NALBI) is superior to calculated albumin/bilirubin (ALBI) grade in predicting overall survival (OS) and progression-free survival (PFS) following chemoembolization (TACE) of hepatocellular carcinoma (HCC)
SIR ePoster library. Wen J. 03/28/20; 289775; 531
Jessica Wen
Jessica Wen
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (1)
Poster Title: Combining neutrophil-lymphocyte ratio (NLR) with serum albumin and bilirubin (NALBI) is superior to calculated albumin/bilirubin (ALBI) grade in predicting overall survival (OS) and progression-free survival (PFS) following chemoembolization (TACE) of hepatocellular carcinoma (HCC)

Poster number: 531

Category: Interventional Oncology: Chemoembolization

Authors: J Wen1, C Cable2, D North2, J Watchmaker3, R Imani-Shikhabadi2, E Hevert2, D Holzwanger4, J Baker2, L Matsuoka2, S Alexopoulos2, T Borgmann2, F Banovac2, D Brown2

Keywords: 0531, Jessica Wen Combining neutrophil-lymphocyte ratio (NLR) with serum albumin and bilirubin (NALBI) is superior to calculated albumin/bilirubin (ALBI) grade in predicting overall survival (OS) and progression-free survival (PFS) following chemoembolization (TACE) of hepatocellular carcinoma (HCC) Combining neutrophil-lymphocyte ratio (NLR) w
Poster Title: Combining neutrophil-lymphocyte ratio (NLR) with serum albumin and bilirubin (NALBI) is superior to calculated albumin/bilirubin (ALBI) grade in predicting overall survival (OS) and progression-free survival (PFS) following chemoembolization (TACE) of hepatocellular carcinoma (HCC)

Poster number: 531

Category: Interventional Oncology: Chemoembolization

Authors: J Wen1, C Cable2, D North2, J Watchmaker3, R Imani-Shikhabadi2, E Hevert2, D Holzwanger4, J Baker2, L Matsuoka2, S Alexopoulos2, T Borgmann2, F Banovac2, D Brown2

Keywords: 0531, Jessica Wen Combining neutrophil-lymphocyte ratio (NLR) with serum albumin and bilirubin (NALBI) is superior to calculated albumin/bilirubin (ALBI) grade in predicting overall survival (OS) and progression-free survival (PFS) following chemoembolization (TACE) of hepatocellular carcinoma (HCC) Combining neutrophil-lymphocyte ratio (NLR) w
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies